AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: Phesgo (Genentech) (phesgo.com)
This is a high-substance, low-BS pharmaceutical site that prioritizes clinical metrics over marketing adjectives. While it employs standard pharma-marketing tropes like metaphorical headings and compensated testimonials, its core value proposition is anchored in measurable time-savings and specific regulatory approvals.
1. Replace the metaphorical H1 PLEASE STAND UP with a direct, substance-led heading such as Subcutaneous HER2+ Treatment in 5 Minutes. 2. Provide ClinicalTrials.gov identifiers (NCT numbers) for the preference study to allow independent verification. 3. Reduce the repetition of the 5-minute claim by consolidating technical timing data into a dedicated comparison table rather than restating it in multiple H2 and H3 headers. 4. Implement Person schema for any healthcare professionals or patient advocates mentioned to strengthen the identity and authority pillar.
Information density is high, with a strong ratio of substance to fluff. Specific metrics are used throughout, such as the 5-minute injection time versus 60-150 minute IV infusions, and the 85 percent patient preference rate. Fluff is concentrated in the H1 PLEASE STAND UP and the Jen’s real PHESGO story heading, but the body text remains highly technical and specific regarding tumor size (greater than 2 cm) and treatment intervals (every 3 weeks).
If your content is buried under div based wrappers, AI will treat it as noise instead of meaning. Check your Machine Readability Index with a free one page structural interpretation.
There is virtually no semantic drift between the homepage and sub-pages. The primary signal on the homepage (speed of administration) is consistently supported by technical data on the What is it sub-page. The hierarchy is coherent, and the identity of the product as a combination therapy (pertuzumab, trastuzumab, and hyaluronidase-zzfx) remains stable across all analyzed content.
Our Authority as a Service model transforms raw diagnostic data into high stakes results. Start your Clinical Strategic Diagnosis for 1 Euro to secure the strategic fixes required for growth.
The trust theatre score is elevated by the presence of a single review_count flag in metadata without a corresponding verified third-party review platform. Additionally, while the site cites a preference study, it relies on Data on file rather than providing direct outbound links to peer-reviewed publications or ClinicalTrials.gov identifiers. The use of actor portrayals and compensated patient testimonials (Jen) also moves the needle toward trust theatre, although it is standard for the industry.
Proof density is very high for the pharmaceutical sector. Verifiable evidence includes the specific drug composition, clear neoadjuvant and adjuvant indications, and precise dosing mL measurements (15 mL injection). The site provides 8+ instances of specific technical evidence across 4 pages, neutralizing the fluff penalties.
To evaluate URL identity stability and multilingual coherence, review the Yoast Identity Stability audit. View the Yoast Identity Stability Audit for a practical example of canonical alignment and language layer integrity.
The site uses a standard pharmaceutical template that is heavily dictated by regulatory requirements, including the persistent and repeated Important Safety Information blocks. While these blocks are boilerplate, they are industry-specific necessities. The value proposition—combining two specific therapies into a 5-minute subcutaneous injection—is unique to this drug and could not be easily copy-pasted by a competitor without the same molecular formulation.
Authority is well-established through Genentech’s Organization schema and clear identification of FDA-approved uses. A minor gap exists in the identity of the testimonials; Jen is a named patient but lacks a digital footprint or Person schema, which is common in HIPAA-sensitive marketing but reduces verifiable authority. The technical implementation of schema (FAQPage, MedicalWebPage) is professional and aligns with the brand’s positioning.
There is no significant disconnect between marketing claims and technical reality. The site claims treatment is faster and proves it with a detailed breakdown of administration times (5-8 minutes vs 60-150 minutes). The clinical preference claim is grounded in a referenced study, even if the raw data is not externally linked.
Medical Devices, Pharma & Biotech BS: Phesgo (Genentech) (phesgo.com)
The website perfectly aligns with the Pharma & Biotech industry category. It features high-density medical terminology, required safety disclosures (ISI), and specific drug indications for HER2-positive breast cancer, consistent with FDA-regulated pharmaceutical communications.
A page with no inbound links is invisible to AI, no matter how strong the content is. Open the Internal Linking Framework Guide to learn how link driven relationships shape retrieval, authority, and entity grouping.
“The low score of 19 is primarily driven by high information density and perfect semantic coherence. The points earned are largely due to pharmaceutical-standard repetition of safety information and the use of 'Data on file' citations which prevent 100 percent external verification. The site successfully avoids generic marketing clichés found in less-regulated industries.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 30, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at Phesgo (Genentech) to view the most current version of their content and see directly what the company offers.